BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 30, 2026
Home
»
Topics
» Gastrointestinal, BioWorld Science
Gastrointestinal, BioWorld Science
RSS
Adolor's ADL-8-2698 enters phase III for second indication
July 11, 2001
Kissei presents new series of D2 antagonists/5-HT4 agonists
July 11, 2001
Bayer HBV compound available for licensing worldwide
July 9, 2001
Aphios and ITC/Immune Technology to develop natural therapeutic for hepatitis C
July 6, 2001
Human fibroblast growth factor gene and use in cirrhosis and cancer
July 5, 2001
Company begins phase I evaluation of XTL-002 for treatment of HCV
July 4, 2001
Schering-Plough seeks FDA approval for new formulation of PEG-Intron
July 4, 2001
Roche licenses levovirin from ICN
July 3, 2001
Novirio establishes marketing agreement for LdT with Sumitomo
July 2, 2001
Adolor's opioid narcotic antagonist completes phase II trials for two indications
July 2, 2001
Previous
1
2
…
533
534
535
536
537
538
539
540
541
…
673
674
Next
RSS